140 filings
Page 5 of 7
6-K
7146gp3u
9 Mar 22
Medicenna Announces Upcoming Poster Presentations at the AACR Annual Meeting
7:15am
6-K
iogamaommbgzse2x
3 Mar 22
Medicenna Announces Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic Advisor
7:10am
6-K
ea60p1r vowxsy5tyy1
10 Feb 22
Medicenna to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
7:05am
6-K
ikcmey6
9 Feb 22
Interim condensed consolidated financial statements of
7:18am
6-K
ew0j dkbhvpr17
2 Feb 22
Current report (foreign)
7:32am
6-K
i4m1zhnubx
31 Jan 22
Medicenna Announces Formation of its Scientific Advisory Board
7:15am
6-K
grsgf9ot9eemxbf67
26 Jan 22
Medicenna Announces Peer-Reviewed Publication of Preclinical Data on MDNA11 in the Journal for ImmunoTherapy of Cancer
8:08am
6-K
ejo7wb2gl55ju g9
18 Jan 22
Medicenna Announces Management Change and Appoints Experienced Development Advisory Committee
7:15am
6-K
6yo 0jw1q4bimruh
5 Jan 22
Medicenna to Participate in Upcoming January Investor Conferences
9:07am
6-K
t21ofdg483poye7d8
22 Dec 21
Current report (foreign)
7:33am
6-K
pupxqlsk26 1t4mkc78
17 Dec 21
Medicenna Receives Regulatory Clearance to Expand the Phase 1/2 ABILITY Study of MDNA11 to Canada
8:00am
6-K
r4lhu2 2cp4zfqe7
18 Nov 21
Current report (foreign)
7:15am
6-K
az25ag6
12 Nov 21
Interim condensed consolidated financial statements of
7:15am
6-K
ha9lq4
9 Nov 21
Medicenna Therapeutics to Present at Stifel’s Virtual Healthcare Conference
8:23am
6-K
4fbqwb 9uk2t0p
4 Nov 21
Current report (foreign)
9:00am
6-K
amfro8l2stu
27 Oct 21
Medicenna Announces FDA Clearance of IND to Expand the Phase 1/2 ABILITY Study of MDNA11 to the United States
8:22am
6-K
7xx z4vzjs
7 Oct 21
Medicenna Presents MDNA11 Data from IND-Enabling Studies at the AACR-NCI-EORTC Conference
9:10am
6-K
ds8i0rtkhn 6wg
23 Sep 21
Medicenna Appoints Dr. John H. Sampson to its Board of Directors
5:28pm
6-K
1yb2k0 ebyms
22 Sep 21
Medicenna Presenting at Next-Gen Cytokine Therapeutics Summit
10:29am
6-K
pnhg 5wnxseetlot09
20 Sep 21
Medicenna Announces Issuance of U.S. Patent Providing Added Intellectual Property Protection for its MDNA11 Program
8:16am